Skip to main navigation Skip to search Skip to main content

Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis

  • Santiago Montes-Moreno
  • , Ana Batlle
  • , Sonia González de Villambrosía
  • , Beatriz Sánchez-Espiridión
  • , Laura Cereceda
  • , Eva González-Barca
  • , Noelia Purroy
  • , Emilia Pardal
  • , Alejandro Martín
  • , Carlos Grande
  • , Francisco Mazorra
  • , Andrés Insunza
  • , Cristina Quero
  • , David Aguiar
  • , Miguel Angel Cruz
  • , Antonio Rueda
  • , Marta Llanos
  • , José Gómez Codina
  • , Francisco Ramón García Arroyo
  • , Dolores Caballero
  • Eulogio Conde, Andrés López, Mariano Provencio, Miguel Piris

Research output: Contribution to journal › Letter › peer-review

Original languageEnglish (US)
Pages (from-to)e138-e141
JournalHaematologica
Volume99
Issue number8
DOIs
StatePublished - Aug 1 2014

Keywords

  • Biological classification
  • Diffuse large B-cell lymphoma
  • Dose-dense therapies
  • High-dose

ASJC Scopus subject areas

  • Hematology

Cite this